Insider Transactions in Q1 2023 at Amicus Therapeutics, Inc. (FOLD)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 03
2023
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
22,116
-2.87%
|
$243,276
$11.93 P/Share
|
|
Jan 03
2023
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,893
-2.3%
|
$86,823
$11.93 P/Share
|
|
Jan 03
2023
|
Ellen Rosenberg Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
77,749
+18.44%
|
-
|
|
Jan 02
2023
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,336
-5.4%
|
$136,032
$12.21 P/Share
|
|
Jan 02
2023
|
Jeff Castelli Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,944
-4.58%
|
$167,328
$12.21 P/Share
|
|
Jan 02
2023
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
27,575
-4.0%
|
$330,900
$12.21 P/Share
|
|
Jan 02
2023
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,165
-4.52%
|
$181,980
$12.21 P/Share
|
|
Jan 02
2023
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
21,596
-2.73%
|
$259,152
$12.21 P/Share
|
|
Jan 02
2023
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,643
-5.22%
|
$175,716
$12.21 P/Share
|